Health and therapeutics: the Limousin at the cutting edge in benchmark fields

Excellence and originality: these are the main features of a sector which has enjoyed ten years of strong growth in the Limousin.

In fields where peoples’ health and wellbeing are at stake, such significant changes in requirements are taking place that new industrial players drawing on university research are experiencing rapid growth.

With its strong research potential focused on priorities identified at national and European levels (the brain and its diseases, immunotherapy-immunomodulation, infectious diseases, cancers, and so on), the Limousin region is home to growing cutting-edge companies drawing directly on research.

With its links to the Cancer-Bio-Health competitiveness cluster, along with the Midi-Pyrenees region, the Limousin is located in the “France Lifescience Corridor”: a network of three “health and biotechnology” competitiveness clusters which are seeking to capture the international market.

There are three principal fields in the Limousin: immunity genomics, the development of approaches in anti-cancer pharmacogenomics, and resistance to anti-bacterial and anti-viral drugs.

In the Limousin, health researchers and entrepreneurs are at the heart of networks geared towards sustainable development for the benefit of as many people as possible.